Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Gaolin Liu"'
Publikováno v:
Cancer & Metabolism, Vol 11, Iss 1, Pp 1-12 (2023)
Abstract Background Hepatocellular carcinoma (HCC) is a principal type of liver cancer with high incidence and mortality rates. Regorafenib is a novel oral multikinase inhibitor for second-line therapy for advanced HCC. However, resistance to regoraf
Externí odkaz:
https://doaj.org/article/77a95b6792a949cf9fd69b129140c48e
Autor:
Niuniu Li, Qiang Wu, Juan Meng, Cheng Feng, Siwei Jiang, Meixia Chen, Wenhui Xu, Fei Wang, Yifan Zhang, Juncai Liu, Cheng Xu, Gaolin Liu, Hong Gao
Publikováno v:
ESC Heart Failure, Vol 10, Iss 4, Pp 2718-2721 (2023)
Abstract Pulmonary arterial hypertension‐targeted therapies in portopulmonary hypertension (PoPH) are scarce, let alone for patients with chronic liver failure (CLF) and hepatopulmonary syndrome (HPS). A 48‐year male was admitted to the hospital
Externí odkaz:
https://doaj.org/article/5a7acfabf0454c169c05bb6f296b21d3
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Cancer stem cells (CSCs) are subpopulations of cells with stem cell characteristics that produce both cancerous and non-tumorigenic cells in tumor tissues. The literature reports that CSCs are closely related to the development of hepatocellular carc
Externí odkaz:
https://doaj.org/article/3917695ae3814fbb8dba68cc976e58d9
Publikováno v:
Journal of Pharmacological Sciences, Vol 138, Iss 2, Pp 107-115 (2018)
The current study investigated whether a Rho-kinase inhibitor alleviated impairments in a rat model of chronic cerebral ischemia and examined the specific pathological mechanisms by which Rho-kinase impacts neuronal damage and cognitive dysfunction.
Externí odkaz:
https://doaj.org/article/28229caf81c74591aa9c608a666d4b75
Publikováno v:
Drug Delivery, Vol 24, Iss 1, Pp 443-451 (2017)
This article reports a promising approach to enhance the oral delivery of nuciferine (NUC), improve its aqueous solubility and bioavailability, and allow its controlled release as well as inhibiting lipid accumulation. NUC-loaded poly lactic-co-glyco
Externí odkaz:
https://doaj.org/article/6caf32eda60d46988cb25e6e20d87a2a
Autor:
Niuniu Li1, Gaolin Liu2, Hong Gao1 luhongzhou@fudan.edu.cn, Qiang Wu1, Juan Meng1, Fei Wang1, Siwei Jiang1, Meixia Chen1, Wenhui Xu1, Yifan Zhang1, Yanjun Wang1, Yingqian Feng1, Juncai Liu1, Cheng Xu1, Hongzhou Lu3 neisanke-01@szsy.sustech.edu.cn
Publikováno v:
BioScience Trends. Aug2023, Vol. 17 Issue 4, p262-270. 9p.
Autor:
Pan Luo, Huiyin Qiu, Yushan Yang, Jiaqi Wu, Xianmin Song, Guorong Fan, Gaolin Liu, Junwei Gao
Publikováno v:
Anti-Cancer Drugs.
This case report describes a 49-year-old woman who diagnosed with acute myeloid leukaemia (AML) harbouring FMS-like tyrosine kinase 3 (FLT3) mutations developed a severe suspected immune-related enteritis during treatment with gilteritinib for mainte
Autor:
Jiguang Lu, Xiao Shen, Hong Zhu, Ying Zhu, Qi Li, Xinyan Liu, Fan Wang, Guorong Fan, Shuowen Wang, Gaolin Liu
Publikováno v:
Anti-Cancer Drugs
The incidence of lung cancer is increasing yearly worldwide, and targeted medicines are the main choice for lung cancer patients. However, there has been no relevant research about the analysis and adjustment of drug combinations for cancer patients
Publikováno v:
Studies in Health Technology & Informatics; 2023, Vol. 308, p619-632, 14p, 3 Diagrams, 2 Charts, 4 Graphs
Autor:
Jing Zhang, Jiuhong Wu, Suodi Zhai, Rongsheng Zhao, Yingchun Xu, Aidong Wen, Xianglin Zhang, Gaolin Liu, Na He, Zhiping Li, Rongsheng Tong, Wei Zhao, Zhigang Chen, Li Wang, Shan Su, Kehu Yang, Xin Hu, Wenting Zhang, Wei Zhou, Xiao Chen, Huizhi Zhang, Guanhua Du, Yang Yang, Daihong Guo, Ruichen Guo, Yalin Dong, Siyan Zhan, Yaolong Chen, Wei Lu, Xin'an Wu, Zhigang Zhao, Minggui Wang, Bikui Zhang, Bei He, Rui Wang, Fan Yang, Jieming Qu, Guang Du, Limei Zhao, Jie Zhang, Youning Liu, Jun Zhang, Zhikang Ye, Dakui Li, Yuan Lv, Huande Li, Xian-Tao Zeng, Chao Zhang, Libo Zhao, Zheng Jiao, Jian Gu, Liyan Miao, Tieying Sun, Yingyuan Zhang
Publikováno v:
Clinical Infectious Diseases. 71:S363-S371
BackgroundClinical practice guidelines or recommendations often require timely and regular updating as new evidence emerges, because this can alter the risk-benefit trade-off. The scientific process of developing and updating guidelines accompanied b